CJC 1295 With DAC

CJC-1295 with DAC is a long-acting synthetic analogue of growth hormone-releasing hormone (GHRH). The drug-affinity complex (DAC) modification is designed to extend the peptide’s interaction with circulating proteins and alter its pharmacokinetic profile. It is studied in controlled research involving GHRH receptor signalling, growth hormone regulation, and downstream endocrine pathways.

This product is prepared for laboratory research use only and may not be used for other purposes. All compounds are supplied in sealed research vials.